GSK-3 alpha isoform-selective antagonists (Biogen)

N/A

Report date: 2025/03/20 15:18:15
NME

Base Information

Drug NameGSK-3 alpha isoform-selective antagonists (Biogen)
Drug Alias NameGSK-3 antagonists (Biogen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitorsGlycogen synthase kinase-3 alpha inhibitors
TargetsGlycogen synthase kinase-3 alphaMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A